Guy Wendy 4

What Happened

• Wendy Guy, Chief Administrative Officer of Processa Pharmaceuticals (PCSA), made an open-market purchase of 2,118 shares on June 15, 2026.
• The shares were acquired at $2.22 per share for a total cost of $4,702. This was a purchase (transaction code P), which is generally viewed as a positive signal relative to sales, though it is a small-dollar buy.

Key Details

• Transaction date and price: 2026-06-15 at $2.22 per share.
• Total acquired: 2,118 shares; total value: $4,702.
• Filing date: Form 4 filed 2026-06-16 (timely reporting for a same-day/next-day filing).
• Shares owned after transaction: not disclosed in the information provided in this summary (refer to the Form 4 for exact beneficial ownership).
• Transaction type/code: Open-market purchase (Code P). No 10b5-1 plan, tax withholding, or other footnotes were indicated in the provided summary.

Context

• This was a straightforward open-market purchase by an executive rather than an option exercise or award. The dollar amount is modest, so while purchases can signal confidence, this single small purchase should be weighed with other insider activity and the company’s broader filings and news.